The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia

被引:75
作者
Newport, MJ
Allen, A
Awomoyi, AA
Dunstan, SJ
McKinney, E
Marchant, A
Sirugo, G
机构
[1] MRC Labs, Banjul, Gambia
[2] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England
[3] Expt Immunol Lab, Brussels, Belgium
基金
英国惠康基金; 英国医学研究理事会;
关键词
genetic susceptibility; tuberculosis; toll-like receptor 4; tumour necrosis factor; interleukin-1; beta; interleukin-10; African populations;
D O I
10.1016/j.tube.2004.02.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Setting: Tuberculosis (TB) remains a major cause of morbidity and mortality worldwide. Studies in a murine model of pulmonary TB have identified a role for Toll-like receptor 4 (TLR4) in the development of chronic lung infection with Mycobacterium tuberculosis. The Asp299Gly polymorphism in the human TLR4 gene is associated with in vivo hyporesponsiveness to lipopolysaccharide (LPS) in Caucasians. Objective: To determine whether TLR4 Asp299Gly influences LPS responses or susceptibility to pulmonary TB in humans in a Gambian population sample. Design: We compared whole blood monokine responses to LIPS in 245 healthy blood donors stratified by TLR4 Asp299Gly genotype to assess whether this polymorphism was functional in this population. A case-control study of 640 subjects was conducted to investigate whether TLR4 Asp299Gly was associated with TB. Results: LPS-induced tumour necrosis factor, interteukin-1beta and interleukin-10 production was not influenced by TLR4 Asp299Gly genotype. There was no association between TLR4 Asp299Gly and TB. Conclusion: Our data suggest that TLR4 Asp299Gly has no influence on monocyte LPS responses or susceptibility to TB in Gambians and could be an ancient neutral polymorphism. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:347 / 352
页数:6
相关论文
共 26 条
[1]   Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice [J].
Abel, B ;
Thieblemon, N ;
Quesniaux, VJF ;
Brown, N ;
Mpagi, J ;
Miyake, K ;
Bihl, F ;
Ryffel, B .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3155-3162
[2]   Influence of interleukin-12 receptor β1 polymorphisms on tuberculosis [J].
Akahoshi, M ;
Nakashima, H ;
Miyake, K ;
Inoue, Y ;
Shimizu, S ;
Tanaka, Y ;
Okada, K ;
Otsuka, T ;
Harada, M .
HUMAN GENETICS, 2003, 112 (03) :237-243
[3]   Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2 [J].
Aliprantis, AO ;
Yang, RB ;
Mark, MR ;
Suggett, S ;
Devaux, B ;
Radolf, JD ;
Klimpel, GR ;
Godowski, P ;
Zychlinsky, A .
SCIENCE, 1999, 285 (5428) :736-739
[4]   Variation in toll-like receptor 4 and susceptibility to group a meningococcal meningitis in Gambian children [J].
Allen, A ;
Obaro, S ;
Bojang, K ;
Awomoyi, AA ;
Greenwood, BM ;
Whittle, H ;
Sirugo, G ;
Newport, MJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (11) :1018-1019
[5]   TLR4 mutations are associated with endotoxin hyporesponsiveness in humans [J].
Arbour, NC ;
Lorenz, E ;
Schutte, BC ;
Zabner, J ;
Kline, JN ;
Jones, M ;
Frees, K ;
Watt, JL ;
Schwartz, DA .
NATURE GENETICS, 2000, 25 (02) :187-+
[6]   Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis [J].
Awomoyi, AA ;
Marchant, A ;
Howson, JMM ;
McAdam, KPWJ ;
Blackwell, JM ;
Newport, MJ .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (12) :1808-1814
[7]   Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors [J].
Brightbill, HD ;
Libraty, DH ;
Krutzik, SR ;
Yang, RB ;
Belisle, JT ;
Bleharski, JR ;
Maitland, M ;
Norgard, MV ;
Plevy, SE ;
Smale, ST ;
Brennan, PJ ;
Bloom, BR ;
Godowski, PJ ;
Modlin, RL .
SCIENCE, 1999, 285 (5428) :732-736
[8]   Genetic dissection of immunity to mycobacteria: The human model [J].
Casanova, JL ;
Abel, L .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :581-620
[9]   Ethnic-specific genetic associations with pulmonary tuberculosis [J].
Delgado, JC ;
Baena, A ;
Thim, S ;
Goldfeld, AE .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (10) :1463-1468
[10]   Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country [J].
Dye, C ;
Scheele, S ;
Dolin, P ;
Pathania, V ;
Raviglione, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :677-686